BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 17827163)

  • 1. Fatal outcome from inappropriate defibrillation.
    Dimitri H; John B; Young GD; Sanders P
    Europace; 2007 Nov; 9(11):1059-60. PubMed ID: 17827163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-long-short sequence caused by ventricular safety pacing inducing ventricular tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
    Hayashi M; Takatsuki S; Messali A; Milliez P; Extramiana F; Leenhardt A
    Europace; 2008 Oct; 10(10):1238-42. PubMed ID: 18617506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
    Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
    Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 6. Initiation of ventricular tachycardia by interruption of pacemaker-mediated tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
    Van Gelder BM; Meijer A; Dekker LR; Bracke FA
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1227-30. PubMed ID: 19719503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of refrigerator-associated 60 Hz alternating current as ventricular fibrillation by an implantable defibrillator.
    Al Khadra AS; Al Jutaily A; Al Shuhri S
    Europace; 2006 Mar; 8(3):175-7. PubMed ID: 16627434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator.
    Vollmann D; Lüthje L; Vonhof S; Unterberg C
    Heart Rhythm; 2005 Mar; 2(3):307-9. PubMed ID: 15851324
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal undersensing of ventricular fibrillation due to intermittent high-amplitude R waves.
    Anguera I; Sabaté X; Sugrañes G; Cequier A
    Pacing Clin Electrophysiol; 2012 Sep; 35(9):e284-6. PubMed ID: 22188442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple inappropriate defibrillator discharges due to Twiddler's syndrome.
    Asbach S; Brunner M; Zehender M; Bode C; Faber TS
    Wien Klin Wochenschr; 2005 Dec; 117(23-24):801. PubMed ID: 16437315
    [No Abstract]   [Full Text] [Related]  

  • 13. Death due to an implantable cardioverter defibrillator.
    Messali A; Thomas O; Chauvin M; Coumel P; Leenhardt A
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):953-6. PubMed ID: 15333095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate detection and therapy from an implantable cardioverter defibrillator due to atrial undersensing.
    Paraskevaidis S; Polymeropoulos K; Vassilikos V; Louridas G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):1002-4. PubMed ID: 16176546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate sensing of pectoral myopotentials by an implantable cardioverter defibrillator system.
    Karanam S; John RM
    Pacing Clin Electrophysiol; 2004 May; 27(5):688-9. PubMed ID: 15125734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 17. Biventricular implantable cardioverter defibrillator use in a patient with heart failure and ventricular tachycardia secondary to Emery-Dreifuss syndrome.
    Walker S; Levy T; Rex S; Paul VE
    Europace; 1999 Jul; 1(3):206-9. PubMed ID: 11225801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation in patients with implantable defibrillators.
    Sakhuja R; Shah AJ; Keebler M; Thakur RK
    Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complication after implantable cardioverter defibrillator implantation: report of 1 case].
    Lou ZY; Zhou MH; Li XQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):360. PubMed ID: 15803642
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator.
    De Ferrari GM; Rordorf R; Frattini F; Petracci B; De Filippo P; Landolina M
    Europace; 2007 Dec; 9(12):1151-7. PubMed ID: 17947251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.